Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SYMLIN safely and effectively. See full prescribing information for SYMLIN. SYMLIN® (pramlintide acetate) injection for subcutaneous useInitial U.S. Approval: 2005
Medication labelWhy this: Advisory · dailymed-prescription
SYMLIN is indicated as an adjunctive treatment in patients with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy.
- generic_name
- pramlintide acetate
- product_names
- pramlintide acetate
- ndc
- 0310-6615, 0310-6615-02, 0310-6627, 0310-6627-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en